Drugmaker Amgen to invest $200 million in India site ... to meet lofty investor expectations and shares of the biotech company fell 4.8% on Tuesday. Novo, Lilly shares rise as Biden proposes ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...